North America

Maintaining robust positions in a challenging marketplace

Throughout 2021, Stallergenes Greer Americas focused on its key strategic pillars to position the business for sustainable long-term growth while delivering high quality services to its stakeholders.

Committed to sustainable long-term growth

Stallergenes Greer, true to its core values of superior customer service, high quality allergen extracts and a legacy of commitment to the specialist community, showed perseverance in overcoming the challenge of the pandemic and continuing to deliver on its purpose.

In 2021, in a competitive marketplace still impacted by the effects of the pandemic, Stallergenes Greer posted stronger top line growth, fuelled by robust performance of human subcutaneous allergen immunotherapy and veterinary segments, whilst maintaining strong positions across all its businesses.

Focusing on supply, quality and operational excellence

As part of its commitment to continuous improvement across its businesses, Stallergenes Greer maintained investments in its infrastructure, processes and people with a focus on supply, quality and operational excellence.

Significant advancements were made throughout the year with the implementation of a state-of-the-art ERP system to increase visibility into the company’s processes, investments in manufacturing to drive quality while yielding higher product, and the development of a lean six sigma training programme for employees.

A trusted partner for its customers

After more than 100 years serving the allergy community in the U.S., Stallergenes Greer continues to be a trusted partner for its customers and is committed to empowering healthcare providers to restore quality of life for people and pets with allergies.

This year, the region again delivered on its promise of next day delivery and developed a series of initiatives to support its customers in an environment still impacted by the COVID-19 pandemic. Stallergenes Greer’s teams were ready and available to assist healthcare professionals to resume their practice and provided medical information, product consultation and training of allergen immunotherapy practice management.

The company continued to offer flexible payment agreements for healthcare professionals and maintained its co-pay assistance programmes for certain patients with a valid Oralair^® prescription.

Strengthening market positions in the U.S. veterinary business

With the rise in pet adoptions still strong in 2021, the veterinary business maintained its solid position with veterinary dermatologists throughout the year. The U.S. teams launched a number of innovative projects to: further improve awareness and management of allergies in pets via initiatives to raise the understanding of the role and value of veterinary dermatologists, support veterinary teams in helping pet owners care for their pet with allergies, and provide education to better understand allergen immunotherapy.

The laboratory teams in Lenoir continue to innovate and advance our veterinary knowledge and extracts offering, including ongoing work achieving even greater consistency in our veterinary mite extracts and advancing understanding of cross reactivity between mite species in veterinary patients.

Canada: delivering growth while adapting to change

Despite restrictions imposed by the pandemic, Stallergenes Greer Canada posted robust growth in 2021 and ended the year slightly above its aspiration. The affiliate maintained stable delivery times throughout the year and continued to serve subcutaneous allergy patients on time, every time.

Sales teams took advantage of social distancing measures to create a virtual meeting space to share ideas, feedback and emerging trends from the field, which allowed the affiliate to develop cohesive messaging across the country and address new opportunities in a broader, more strategic and more agile manner.

Undeterred by limited face to face interactions with patients and healthcare professionals, Stallergenes Greer Canada broadened its reach and impact by converting many of its activities, patient education tools and interactions with physicians to virtual and online formats. The affiliate notably created a network of physicians to discuss interesting cases, best practices, challenges, and ideas. In small groups, they were able to exchange with colleagues that they wouldn't have interacted with in pre-COVID times.

Together with CSACI (Canadian Society of Allergy and Clinical Immunology), Stallergenes Greer Canada also sponsored the first "Woman in Allergy" conference, connecting female allergists from across the country to discuss their unique challenges, to learn from each other and from inspiring female leaders from Canada and the U.S.